The novel and recurrent variants in exon 31 of CREBBP in Japanese patients with Menke–Hennekam syndrome

American Journal of Medical Genetics Part A ◽

10.1002/ajmg.a.62533 ◽

2021 ◽

Author(s):

Eriko Nishi ◽

Toshiki Takenouchi ◽

Fuyuki Miya ◽

Tomoko Uehara ◽

Kumiko Yanagi ◽

...

Keyword(s):

Japanese Patients ◽

The Novel ◽

Hennekam Syndrome

Download Full-text

Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

International Journal of Urology ◽

10.1111/iju.13715 ◽

2018 ◽

Vol 25 (7) ◽

pp. 677-677

Author(s):

Christopher R Chapple

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Prospective Study ◽

Japanese Patients ◽

Phase Iii ◽

The Novel ◽

Safety And Efficacy

Download Full-text

Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1)

Journal of Infection and Chemotherapy ◽

10.1007/s10156-009-0006-3 ◽

2010 ◽

Vol 16 (1) ◽

pp. 62-63

Author(s):

Kenji Ohnishi ◽

Fukumi Nakamura-Uchiyama

Keyword(s):

Influenza A ◽

Japanese Patients ◽

The Novel ◽

Neuraminidase Inhibitors ◽

Influenza A H1n1 ◽

Novel Influenza A

Download Full-text

Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

International Journal of Urology ◽

10.1111/j.1442-2042.2008.02152.x ◽

2008 ◽

Vol 15 (11) ◽

pp. 986-991 ◽

Author(s):

Yukio Homma ◽

Osamu Yamaguchi

Keyword(s):

Overactive Bladder ◽

Japanese Patients ◽

Download Full-text

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

Cardiovascular Diabetology ◽

10.1186/1475-2840-13-65 ◽

2014 ◽

Vol 13 (1) ◽

pp. 65 ◽

Author(s):

Kohei Kaku ◽

Hirotaka Watada ◽

Yasuhiko Iwamoto ◽

Kazunori Utsunomiya ◽

Yasuo Terauchi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

The Novel ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Sodium Glucose Cotransporter ◽

Download Full-text

Faculty Opinions recommendation of Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123768.580848 ◽

2008 ◽

Author(s):

Rodolfo Testa

Keyword(s):

Overactive Bladder ◽

Japanese Patients ◽

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723005598.793516772 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Japanese Patients ◽

Controlled Clinical Trial ◽

The Novel ◽

Double Blind ◽

Male And Female ◽

Double Blind Placebo ◽

Irritable Bowel ◽

Download Full-text

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

International Journal of Urology ◽

10.1111/j.1442-2042.2009.02286.x ◽

2009 ◽

Vol 16 (5) ◽

pp. 499-506 ◽

Author(s):

Yukio Homma ◽

Osamu Yamaguchi ◽

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Japanese Patients ◽

The Novel ◽

Antimuscarinic Agent ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety of the Novel Protease-Activated Receptor-1 Antagonist Vorapaxar in Japanese Patients with a History of Ischemic Stroke

Journal of Stroke and Cerebrovascular Diseases ◽

10.1016/j.jstrokecerebrovasdis.2010.09.005 ◽

2012 ◽

Vol 21 (4) ◽

pp. 318-324 ◽

Author(s):

Yukito Shinohara ◽

Shinya Goto ◽

Masaki Doi ◽

Peder Jensen

Keyword(s):

Ischemic Stroke ◽

Japanese Patients ◽

The Novel ◽

Protease Activated Receptor 1

Download Full-text

Editorial Comment from Dr Yamanishi to Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

International Journal of Urology ◽

10.1111/iju.13714 ◽

2018 ◽

Vol 25 (7) ◽

pp. 676-676

Author(s):

Tomonori Yamanishi

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Prospective Study ◽

Japanese Patients ◽

Phase Iii ◽

The Novel ◽

Safety And Efficacy

Download Full-text

Nocardia exalbida sp. nov., isolated from Japanese patients with nocardiosis

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY ◽

10.1099/ijs.0.63850-0 ◽

2006 ◽

Vol 56 (6) ◽

pp. 1193-1196 ◽

Author(s):

Soji Iida ◽

Akiko Kageyama ◽

Katsukiyo Yazawa ◽

Noboru Uchiyama ◽

Takafumi Toyohara ◽

...

Keyword(s):

Type Strain ◽

Gene Sequence ◽

Novel Species ◽

Japanese Patients ◽

Rrna Gene ◽

The Novel ◽

Bacterial Strains ◽

Polyphasic Analysis ◽

Phenotypic Properties ◽

Sequence Similarities

Two bacterial strains isolated from different hospitals in Japan were subjected to a polyphasic analysis. Strains IFM 0803T and IFM 10383 were found to have morphological, biochemical, physiological and chemotaxonomic properties consistent with their classification in the genus Nocardia. Strains IFM 0803T and IFM 10383 clustered with the type strain of Nocardia xishanensis, showing 16S rRNA gene sequence similarities of 98.6–98.9 % with this species. The novel strains could be distinguished from N. xishanensis by a range of phenotypic properties. Based on their phenotypic and phylogenetic characteristics, the two isolates are proposed as members of a novel species of the genus Nocardia, Nocardia exalbida sp. nov., with the type strain IFM 0803T (=NBRC 100660T=JCM 12667T=DSM 44883T).

Download Full-text